TGF Beta 3 - Clinical Research

Clinical Research

After successful phase I/II trials, human recombinant TGF-β3 (Avotermin, planned trade name Juvista) failed in Phase III trials.

Read more about this topic:  TGF Beta 3

Famous quotes containing the word research:

    The great question that has never been answered and which I have not get been able to answer, despite my thirty years of research into the feminine soul, is “What does a women want?”
    Sigmund Freud (1856–1939)